140 related articles for article (PubMed ID: 16054017)
21. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
[TBL] [Abstract][Full Text] [Related]
22. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
[TBL] [Abstract][Full Text] [Related]
23. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.
Kandasamy K; Srivastava RK
Cancer Res; 2002 Sep; 62(17):4929-37. PubMed ID: 12208743
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PCc-3 prostate cancer cells.
Beresford SA; Davies MA; Gallick GE; Donato NJ
J Interferon Cytokine Res; 2001 May; 21(5):313-22. PubMed ID: 11429162
[TBL] [Abstract][Full Text] [Related]
25. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.
Pianetti S; Arsura M; Romieu-Mourez R; Coffey RJ; Sonenshein GE
Oncogene; 2001 Mar; 20(11):1287-99. PubMed ID: 11313873
[TBL] [Abstract][Full Text] [Related]
26. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells.
Lee BC; Lee TH; Avraham S; Avraham HK
Mol Cancer Res; 2004 Jun; 2(6):327-38. PubMed ID: 15235108
[TBL] [Abstract][Full Text] [Related]
27. Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway.
Basile JR; Afkhami T; Gutkind JS
Mol Cell Biol; 2005 Aug; 25(16):6889-98. PubMed ID: 16055703
[TBL] [Abstract][Full Text] [Related]
28. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line.
Lee S; Choi EJ; Jin C; Kim DH
Gynecol Oncol; 2005 Apr; 97(1):26-34. PubMed ID: 15790433
[TBL] [Abstract][Full Text] [Related]
29. Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo.
Saito Y; Swanson X; Mhashilkar AM; Oida Y; Schrock R; Branch CD; Chada S; Zumstein L; Ramesh R
Gene Ther; 2003 Nov; 10(23):1961-9. PubMed ID: 14528320
[TBL] [Abstract][Full Text] [Related]
30. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells.
Tanno S; Tanno S; Mitsuuchi Y; Altomare DA; Xiao GH; Testa JR
Cancer Res; 2001 Jan; 61(2):589-93. PubMed ID: 11212254
[TBL] [Abstract][Full Text] [Related]
31. The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells.
Maier D; Jones G; Li X; Schönthal AH; Gratzl O; Van Meir EG; Merlo A
Cancer Res; 1999 Nov; 59(21):5479-82. PubMed ID: 10554022
[TBL] [Abstract][Full Text] [Related]
32. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma.
Pene F; Claessens YE; Muller O; Viguié F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D
Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis.
Gomez-Manzano C; Fueyo J; Jiang H; Glass TL; Lee HY; Hu M; Liu JL; Jasti SL; Liu TJ; Conrad CA; Yung WK
Ann Neurol; 2003 Jan; 53(1):109-17. PubMed ID: 12509854
[TBL] [Abstract][Full Text] [Related]
34. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
35. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L
Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779
[TBL] [Abstract][Full Text] [Related]
36. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones.
Erdös EG; Skidgel RA
FASEB J; 1989 Feb; 3(2):145-51. PubMed ID: 2521610
[TBL] [Abstract][Full Text] [Related]
37. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas.
Tamura M; Gu J; Takino T; Yamada KM
Cancer Res; 1999 Jan; 59(2):442-9. PubMed ID: 9927060
[TBL] [Abstract][Full Text] [Related]
38. Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells.
Yang CM; Lin MI; Hsieh HL; Sun CC; Ma YH; Hsiao LD
J Cell Physiol; 2005 Jun; 203(3):538-46. PubMed ID: 15573401
[TBL] [Abstract][Full Text] [Related]
39. CD10/neutral endopeptidase 24.11 is phosphorylated by casein kinase II and coassociates with other phosphoproteins including the lyn src-related kinase.
Ganju RK; Shpektor RG; Brenner DG; Shipp MA
Blood; 1996 Dec; 88(11):4159-65. PubMed ID: 8943850
[TBL] [Abstract][Full Text] [Related]
40. In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis.
Chesire DR; Ewing CM; Gage WR; Isaacs WB
Oncogene; 2002 Apr; 21(17):2679-94. PubMed ID: 11965541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
